Business
Merck pill could cut COVID risk in half but won’t be a ‘miracle’ cure for coronavirus, scientists say – ABC News
An antiviral pill developed by US drug maker Merck could halve the chances of dying or being hospitalised from COVID-19, but…
An antiviral pill developed by US drug maker Merck could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, with experts hailing it as a potential breakthrough in how the virus is treated.
Key points:
…
Continue Reading
-
General21 hours agoActivism under the guise of good intentions
-
Noosa News21 hours agoHow errors, penalties and bad decisions helped New South Wales beat themselves in Origin II
-
Business14 hours agoWhy this speculative ASX stock could rise 100%+
-
General17 hours agoUS Fed keeps rates unchanged, expects two cuts in 2025